CTSH vs REPL · P/E 12, rev $19.74B vs $825.7M cap
Cognizant Technology Solutions Corp Class A (CTSH) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Cognizant Technology Solutions Corp Class A (CTSH) is a information technology services company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported CTSH revenue for 2024-12-31 was $19.74B. Net income was $2.24B. Revenue was up 2.0% from 2023-12-31 to 2024-12-31. CTSH currently screens at market cap $25.17B and trailing P/E 11.5.
REPL does not have a complete income-statement cache yet.
CTSH currently screens at market cap $25.17B and trailing P/E 11.5. REPL currently screens at market cap $825.7M.
Not investment advice. Open the CTSH and REPL stock pages for the full models.
Not investment advice.